Investigators concluded, “To our knowledge, this is the first longitudinal cohort study … to report an absence of a relationship between cannabis use and risk of AF.”
Researchers “did not find evidence of increases in health service use or incident cases of psychotic disorders over the short-term (17 month) period following cannabis legalization.”
“This is the first population-level prospective study to contribute evidence that medical cannabis is safe for a wide variety of symptoms,” investigators concluded.